GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Short-Term Capital Lease Obligation

Organon Pharma Indonesia PT (ISX:SCPI) Short-Term Capital Lease Obligation : Rp0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Short-Term Capital Lease Obligation?

Organon Pharma Indonesia PT's Short-Term Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil.


Organon Pharma Indonesia PT Short-Term Capital Lease Obligation Historical Data

The historical data trend for Organon Pharma Indonesia PT's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Short-Term Capital Lease Obligation Chart

Organon Pharma Indonesia PT Annual Data
Trend
Short-Term Capital Lease Obligation

Organon Pharma Indonesia PT Quarterly Data
Short-Term Capital Lease Obligation

Organon Pharma Indonesia PT Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Organon Pharma Indonesia PT Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines